Kansas City Southern (KSU), Cheniere Energy Inc. (LNG), Xencor Inc (XNCR): Viking Global Continues to Bet Big; Adage Capital Increase its Stake

Page 2 of 2

Viking Global also increased its position in Cheniere Energy, Inc. (NYSEAMEX:LNG), a stock it initially acquired in the third quarter of 2014. This stock has performed very well over the past year, gaining around 77% since February of last year. Furthermore, the company also has the backing of Seth Klarman’s Baupost Group, which recently acquired an additional 13.6 million shares, thus doubling its stake in the liquefied natural gas producer.  The investment firm is the largest institutional investor backing Cheniere Energy, Inc. (NYSEAMEX:LNG), with a holding of 24.8 million shares. Michael Lowenstein’s Kensico Capital is also betting on the company, boasting a position of 7.8 million shares, which accounts for almost 14% of its equity portfolio.

Adage Capital Management was also active in the past few days, disclosing an increase to its holding in Xencor Inc (NASDAQ:XNCR). The investment firm has held this stock in its equity portfolio since its 2013 fourth quarter 13F filing, when it revealed a stake of 820,000 shares in the company. This proved to be a savvy investment, as the stock gained more than 74% throughout 2014. Although share prices took a dip over the past week, there is ample reason to remain bullish regarding the biopharmaceutical company. In addition to Adage Capital, Xencor Inc (NASDAQ:XNCR) is backed by Joseph Edelman’s Perceptive Advisors, which is its largest institutional investor, boasting a position of 1.9 million shares.

Adage Capital Management is a Boston-based hedge fund that was founded by former Harvard Management Company analysts Phillip Gross and Robert Atchinson in 2001. By employing fundamental analysis, along with intra-industry valuation methods, to make its investments, the fund has amassed an equity portfolio valued at around $40.4 billion. The firm’s equity portfolio is highly diversified and balanced, with its largest position – comprised of Puma Biotechnology Inc (NYSE:PBYI) stock – accounting for only 3.35% of its total holdings.

Disclosure: none.

Page 2 of 2